Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives
Tóm tắt
Lung cancer is the leading cause of cancer mortality worldwide. Dendritic cells (DCs) are the key factors providing protective immunity against lung tumors and clinical trials have proven that DC function is reduced in lung cancer patients. It is evident that the immunoregulatory network may play a key role in the failure of the immune response to terminate tumors. Lung tumors likely employ numerous strategies to suppress DC‐based anti‐tumor immunity. Here, we summarize the recent advances in our understanding on lung tumor‐induced immunosuppression in DCs, which affects the initiation and development of T‐cell responses. We also describe which existing measures to restore DC function may be useful for clinical treatment of lung tumors. Furthering our knowledge of how lung cancer cells alter DC function to generate a tumor‐supportive environment will be essential in order to guide the design of new immunotherapy strategies for clinical use.
Từ khóa
Tài liệu tham khảo
Hersom M, 2018, Companion and complementary diagnostics‐focus on PD‐L1 expression assays for PD‐1/PD‐L1 checkpoint inhibitors in non‐small cell lung cancer, Ther Drug Monit, 40, 9, 10.1097/FTD.0000000000000460
Gonzalez‐Cao M, 2015, Targeting PD‐1/PD‐L1 in lung cancer: current perspectives, Lung Cancer (Auckl), 6, 55
Fatima F, 2015, Stem cell‐derived exosomes: roles in stromal remodeling, tumor progression, and cancer immunotherapy, Chin J Cancer, 34, 541
Shang N, 2017, Dendritic cells based immunotherapy, Am J Cancer Res., 7, 2091
Liu C, 2008, Plasmacytoid dendritic cells induce NK cell‐dependent, tumor antigen‐specific T cell cross‐priming and tumor regression in mice, J Clin Invest, 118, 1165
Zhang C, 2017, The effect of semimature dendritic cell and the levels of Treg on transplantation tolerance of hepatocytes differentiated from mouse embryonic stem cell, Zhonghua Yi Xue Za Zhi, 97, 259
Niki M, 2017, New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non‐small‐cell lung cancer, Lung Cancer (Auckl), 8, 91
Obleukhova I, 2018, Use of antigen‐primed dendritic cells for inducing antitumor immune responses in vitro in patients with non‐small cell lung cancer, Oncol Lett, 15, 1297
Geskin LJ, 2018, Three antigen‐loading methods in dendritic cell vaccines for metastatic melanoma, Melanoma Res., 28, 211, 10.1097/CMR.0000000000000441
Chakravarty PK, 1999, Flt3‐ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer, Cancer Res., 59, 6028
SomaiahN et al.First‐in‐class first‐in‐human study evaluating LV305 a dendritic‐cell tropic lentiviral vector in sarcoma and other solid tumors expressing NY‐ESO‐1.Clin Cancer Res.2019;10.1158/1078‐0432.CCR‐19‐102531227504